Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Regeneron Pharmaceuticals, Inc.
(NQ:
REGN
)
266.97
USD
+2.31 (+0.87%)
Official Closing Price
/ Updated:
4:00 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Regeneron Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Regeneron Pharmaceuticals: The Stock That Only Goes Up?
May 01, 2013
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN ) were trading at new all-time high levels on Wednesday afternoon on concerns that rival Allergan (NYSE: AGN ) may have problems moving its unnamed...
Read More
category
Benzinga
,
REGN
,
Movers
, and 10 more.
from
Latest Articles from Benzinga.com
Market Wrap for Wednesday, May 1: Stocks Fall as Employment Data Weakens in April
May 01, 2013
The U.S. stock market was hit hard on Wednesday as investors reacted to a report which showed slowing employment conditions for the month of April. The losses were also likely amplified by profit...
Read More
category
Earnings
,
Benzinga
,
REGN
, and 25 more.
from
Latest Articles from Benzinga.com
Notable 52-Week Highs and Lows of the Day 05/01: (SIRI) (VIAB) (REGN) High; (ANV) (MELA) Low
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294886 for the full story.
Read More
from
StreetInsider.com News Articles
Analyst Moves: ECL, ESRX, REGN
May 01, 2013
This morning, Credit Suisse increased its price target on shares of Ecolab (ECL) to $86 following strong earnings from the company yesterday. In the report, Credit Suisse increased its EPS estimates...
Read More
category
Stocks
from
Market News Video
Manufacturing Index Slips, Markets Extend Losses
May 01, 2013
The markets extended its losses during the midday with the Dow dropping 76 points to 14,763 as expansion of manufacturing activity slowed in April. Nasdaq fell 21 points to 3307.
Read More
category
Market News
from
MarketMinute.com Market Updates
Midday Movers: H, AMT, ICE & More
May 01, 2013
Take a look at some of Wednesday's midday movers:
Read More
category
Regeneron Pharmaceuticals Inc
,
Realogy Corp
,
Estee Lauder Companies Inc
, and 7 more.
from
CNBC.com News
Reduced Competition Adds $35 to Regeneron (REGN) DCF, Deutsche Bank Raises PT to $310
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294408 for the full story.
Read More
from
StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 05/01: (IQNT) (BCOV) (MSPD) Higher; (CRAY) (RBC) (LEDS) Lower
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294357 for the full story.
Read More
from
StreetInsider.com News Articles
Streetinsider.com's Hot Lunchtime Reads 05/01: (TMUS) (AAPL) (AET) (DDD) (AGN)
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294277 for the full story.
Read More
from
StreetInsider.com News Articles
Regeneron Pharmaceuticals Crosses Above its 10-day MA (REGN)
May 01, 2013
from
Comtex SmarTrend® News Briefs
Allergan (AGN) Says DARPin to Be Delayed, Shares Sag; Regeneron (REGN) Ramps Higher
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294051 for the full story.
Read More
from
StreetInsider.com News Articles
BRIEF-Regeneron Pharma shares resume trading, up 16 percent
May 01, 2013
NEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval
Read More
category
companyNews
from
Reuters: Company News
BRIEF-Allergan resumes trading down 11.5 percent after company says phase 2 eye drug data does not support directly moving to phase 3
May 01, 2013
NEW YORK, May 1 (Reuters) - Allergan Inc : * Resumes trading down 11.5 percent after company says phase 2 Darpin eye drug data does not support directly moving to phase 3
Read More
category
companyNews
from
Reuters: Company News
Regeneron (REGN) Share Spike, Volatility Halt Appears Related to Allergan News
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8294005 for the full story.
Read More
from
StreetInsider.com News Articles
BRIEF-Regeneron Pharma shares halted, last up 14.3 pct
May 01, 2013
NEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares halted, last up 14.3 percent
Read More
category
companyNews
from
Reuters: Company News
Regeneron (REGN) trading paused for volatility
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8293977 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Goldman Sachs Raises PT on Regeneron Pharmaceuticals Following Cardiologist/Lipidologist Survey
May 01, 2013
In a report published Wednesday, Goldman Sachs analyst Terence Flynn reiterated a Buy rating on Regeneron Pharmaceuticals (NASDAQ: REGN ), and raised the price target from $230.00 to $240.00. In the...
Read More
category
Goldman Sachs
,
Benzinga
,
REGN
, and 3 more.
from
Latest Articles from Benzinga.com
Ampio Pharma Initiates Phase III, Investors Extend Momentum
May 01, 2013
Ampio Pharma Initiates Phase III, Investors Extend Momentum Shares of Ampio Pharmaceuticals (NASDAQ: AMPE) are on a roll after the company reported on April 24th that they had completed enrollment for...
Read More
category
Prime Content
,
Bio/Wire
,
AMPE
from
Bio-Wire.Com
Regeneron Pharmaceuticals - Unusual Options Volume
May 01, 2013
NEW YORK (AVAFIN) -- Regeneron Pharmaceuticals options set a new 90-day record for the ...
Read More
from
AVAFIN
Wall Street Gets It Backward On Amgen Cholesterol Drug
April 29, 2013
Shares of Aegerion Pharmaceuticals have risen 200% since October on hopes that the company’s drug Juxtapid, a treatment for a rare genetic disease that causes super-high cholesterol and early heart...
Read More
category
NYSE:SNY
,
NASDAQ:REGN
,
NASDAQ:ISIS
, and 2 more.
from
Forbes Real Time
Analyst Moves: WYNN, VFC, REGN
April 29, 2013
This morning, Morgan Stanley increased its price target on shares of Wynn Resorts (WYNN) to $140 as Macau's growth and Las Vegas' cost cutting should improve earnings at the casino operator. In the...
Read More
category
Stocks
from
Market News Video
Top 10 News Items for 04/22 - 04/26: Apple's Lukewarm Report; Social Media Becomes Dangerous; Q1 GDP Accelerates, Misses
April 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8283082 for the full story.
Read More
from
StreetInsider.com News Articles
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 34 more.
from
Latest Articles from Benzinga.com
Regeneron Pharmaceuticals Shares Up 25.8% Since SmarTrend's Buy Recommendation (REGN)
April 26, 2013
from
Comtex SmarTrend® News Briefs
StreetInsider.com Pre-Open Movers 4/25: (AKAM) (INFN) (FIO) Higher; (XIDE) (INTU) (CTXS) Lower (more...)
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8278305 for the full story.
Read More
from
StreetInsider.com News Articles
Early Movers: XOM, MMM, UPS & More
April 25, 2013
These are the stocks posting the largest moves before the bell.
Read More
category
Regeneron Pharmaceuticals Inc
,
United Parcel Service
,
Exxon Mobil Corp
, and 34 more.
from
CNBC.com News
Market Wrap: Regeneron Gets S&P 500 Spot; Durable Orders Tumble; Qualcomm Edges-Out Q2 Views
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8276566 for the full story.
Read More
from
StreetInsider.com News Articles
Streetinsider.com After-Hours Movers 4/24: (AKAM) (FIO) (ANGI) Higher; (CTXS) (EQIX) (ZNGA) Lower (more...)
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8276559 for the full story.
Read More
from
StreetInsider.com News Articles
BRIEF-Regeneron Pharma shares up 2.8 pct after the bell
April 24, 2013
NEW YORK, April 24 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares up 2.8 percent after the bell, to join S&P 500 next week
Read More
category
companyNews
from
Reuters: Company News
After-Hours Buzz: QCOM, ZNGA, AKAM & More
April 24, 2013
Check out which companies are making headlines after the bell Wednesday:
Read More
category
Regeneron Pharmaceuticals Inc
,
Lam Research Corporation
,
Economics
, and 22 more.
from
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here